Tags : Ian Tomlinson

Original

PharmEnable secures £1.8 million Seed investment led by Cambridge Enterprise

Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion £1.8m seed financing led by Cambridge Enterprise alongside angel investors and life science investment funds Using advanced medicinal chemistry and AI approaches to develop highly complex and specific drug candidate molecules Will enable in-house drug discovery across a number of therapeutic areas including cancer and […]Read More